legalhealthcare3.83 min read
"DOJ Alleges Fraudulent Price Reporting by Regeneron Pharmaceuticals for Eylea Drug"
1 year ago•Source: Department of Justice
Legalhealthcare News
The latest legalhealthcare stories, summarized by AI
Featured Legalhealthcare Stories
View original source
3.11 min•1 year ago
"Supreme Court Considers Abortion Pill Access in Landmark Case"
The Supreme Court is considering a challenge to the FDA's approval process for the abortion pill mifepristone, which has widespread availability. The case, brought by anti-abortion doctors, questions the FDA's evaluation of the drug's safety risks. The outcome could have significant practical effects on abortion access, especially in the wake of the Supreme Court's decision to overturn Roe v. Wade. The court may also consider whether the challengers have legal standing to bring the lawsuit.
More Top Stories
2
Texas Judge Dismisses Big Pharma Lawsuit Against Medicare Price Negotiations
Newsweek•1 year ago
3
Texas AG Ken Paxton Continues Pursuit of Transgender Youths' Medical Records from Out-of-State Providers
The Washington Post•1 year ago
More Legalhealthcare Stories
Supreme Court to Hear High-Stakes Abortion Pill Case in March
Originally Published 1 year ago — by POLITICO
The Supreme Court has scheduled oral arguments for March 26 in a case challenging policies expanding access to the abortion pill, mifepristone. The case could impact healthcare for millions and potentially roll back access to the pill, affecting those in states that protect abortion rights. The Biden administration, medical societies, and pharmaceutical companies argue for the drug's safety, while opponents claim inadequate safety studies. The decision, expected in June, could have far-reaching implications for access to reproductive healthcare.
"Johnson & Johnson Settles Talc Baby Powder Claims for $700 Million"
Originally Published 1 year ago — by BBC.com
Johnson & Johnson has reached a tentative $700m deal with over 40 US states regarding the investigation of its talc-based baby powder and other products. The company faces over 50,000 cases from people claiming the product caused cancer, with some alleging it contained asbestos. J&J has maintained the products were safe, but has faced significant legal battles and losses. The reported resolution of the state matters is seen as a step towards a global talc powder settlement in 2024.
Supreme Court Set to Rule on Abortion Pill Access and Restrictions
Originally Published 2 years ago — by NBC News
The Supreme Court has agreed to hear a case regarding the accessibility of the abortion pill, mifepristone, which is commonly used for medication abortions. The court will review appeals from the Biden administration and drugmaker Danco defending FDA decisions that made it easier to access and use the pill, including by mail. The case raises questions about the court's stance on abortion rights and the FDA's process for approving drugs. The ruling, expected by June, could have significant implications for abortion access in the United States.
Supreme Court Examines Legal Shield for Sackler Family in $6bn Deal
Originally Published 2 years ago — by BBC.com
The US Supreme Court is considering a bankruptcy deal for Purdue Pharma, the maker of OxyContin, which may shield the Sackler family from future lawsuits related to the opioid crisis. The deal, which granted the family immunity in civil cases, has faced criticism from US officials who argue it conflicts with bankruptcy law. While some families impacted by the drug support the deal, others want the Supreme Court to overturn it and hold the Sacklers accountable. The court's ruling will have significant implications for bankruptcy law and the ability of third parties to receive immunity in such cases.
Supreme Court's Decision on OxyContin Maker's Bankruptcy Deal Holds Billions at Stake
Originally Published 2 years ago — by The Associated Press
The Supreme Court is hearing arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield the Sackler family, who own the company, from civil lawsuits related to the toll of opioids. The agreement, which would provide billions of dollars to combat the opioid epidemic, has been put on hold due to objections from the Biden administration. The issue at hand is whether bankruptcy protection can be extended to individuals like the Sacklers who have not declared bankruptcy themselves. Lower courts have issued conflicting decisions on this matter, which has implications for other major product liability lawsuits settled through bankruptcy. The decision is expected by early summer.
"Controversial 'Take Care of Maya' Trial: Hospital Faces Lawsuit Over Multi-Million Dollar Payout"
Originally Published 2 years ago — by The Indian Express
A jury in Florida has awarded $261 million in damages to a family who accused Johns Hopkins Hospital of false imprisonment, battery, and medical negligence, including preventing them from seeing their daughter while she was placed there. The daughter, Maya Kowalski, has also filed additional charges of assault and sexual abuse against the hospital. The family's story was the subject of a Netflix documentary titled "Take Care of Maya." The case revolves around Maya's debilitating pain and her mother's alleged Munchausen syndrome by proxy, which led to their separation and the mother's subsequent suicide.
"Texas AG Takes Legal Action Against Pfizer for Selling Ineffective Medicine and Manipulating Test Results"
Originally Published 2 years ago — by Fox Business
Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer and Tris Pharma, accusing them of defrauding the state by providing ineffective medicine. Paxton alleges that Pfizer and Tris manipulated quality-test results to obtain Medicaid reimbursement for their ADHD medication, Quillivant XR. The lawsuit claims that the companies concealed manufacturing issues and failed to disclose them to Medicaid providers, potentially endangering children. The state of Texas is seeking monetary payments and civil penalties for the alleged violations.
Diabetic Inmate Files Lawsuit Alleging Withheld Insulin by Idaho Medical Provider
Originally Published 2 years ago — by East Idaho News
A Type 1 diabetic prisoner in Idaho has filed a civil rights lawsuit against Centurion Health, the medical provider for the Idaho Department of Correction, alleging mishandling of his diabetes and refusal to provide him with an insulin pump and glucometer. The lawsuit claims that the prisoner's blood glucose levels have been poorly controlled for nearly three years, resulting in frequent disruptions to his schedule and symptoms of diabetic ketoacidosis. The lawsuit also highlights previous instances of inadequate medical care, including delayed treatment for a broken ankle. The Idaho Department of Correction and Centurion Health have not yet responded to the allegations.
Michigan Senate Takes Action on Auto Insurance and Drug Laws
Originally Published 2 years ago — by UpNorthLive.com
Michigan residents may soon have the ability to sue drug manufacturers and sellers for harm caused by FDA-approved pharmaceutical drugs, thanks to a bill passed by the Michigan Senate. For the past 28 years, Michigan has had immunity protections for pharmaceutical companies, preventing residents from seeking legal recourse or financial compensation. The bill, which received bipartisan support, aims to remove this immunity and allow residents to hold companies accountable. Michigan's strong corporate liability shield has resulted in the state missing out on potential payouts from major pharma litigation cases. However, it is unlikely that residents will be able to retroactively receive compensation for missed opportunities. The Michigan Chamber of Commerce opposes the bill, while pharmaceutical researchers argue that it would burden the industry with greater liability costs. The bill now moves to the Michigan House.
Indiana Attorney General Files Lawsuit Against Hospital System for Violating Privacy of Ohio Girl Seeking Abortion
Originally Published 2 years ago — by NBC News
Indiana's attorney general has filed a lawsuit against the state's largest hospital system, accusing it of violating patient privacy laws by allowing a doctor to publicly share the story of a 10-year-old Ohio girl who traveled to Indiana for an abortion. The lawsuit comes after the doctor's account became a focal point in the abortion debate following the Supreme Court's overturning of Roe v. Wade. The hospital system denies violating privacy laws and states that it will respond directly to the attorney general's office.